Treat this as a private company and you'll be able to sleep at night.
BGT only listed late November, give it some time. Many stocks I've made solid money in traded under IPO price before taking off SAS, RAP, GMV, ELS, MYQ to name a few. I believe Bio-Gene will be the same.
This year the foundations are being built with data being collected, BGT aim to file a classification of their mode of action with IRAC by December. Every major agchem company will then be chasing BGT in 2019.
Take this statistic, $16B+ US per year insecticide market with no novel solution to date. This company is very marketable once further testing results come out and don't be surprised if this re-rates to a $300M+ valuation.
Time will tell but I am happy to take the risk from here.
Add to My Watchlist
What is My Watchlist?
